Global Sugar Coated Tablets review
Global Sugar Coated Tablets review

Sugar Coated Tablets Comprehensive Study by Type (Colored Sugar Coated Tablets, Colorless Sugar Coated Tablets), Application (Cardiovascular Diseases, Gastrointestinal Disease, Neurological Diseases, Immune Disease, Gynaecological, Orthopaedic diseases, Others), Binders (Polyvinyl Acetate (PVA), Polyvinyl Pyrrolidone (PVP), Cellulose, Others) Players and Region - Global Market Outlook to 2025

Sugar Coated Tablets Market Segmented into XX Submarkets. | Forecast Years: 2021- 2025  

Feb 2021 Edition 217 Pages 220 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Sugar Coated Tablets?
Tablets helps for the administration of drugs via the oral route. It is used to treat several types of diseases. Sugar-coated tablets manufacturing is carried out by covering all standard manufacturing process with fixed parameters. Sugar-coated tablets comprises of high degree gloss and they are available in coloured and colourless form. Sugar coatings protects the tablet contents from stomach acids, it also protects the stomach lining from aggressive drugs such as enteric coated aspirin. This sugar coatings are acts as barrier for external contaminants. It help to mask the unsavoury taste of the drug which may unpalatable for some patients. They are generally water-soluble which helps it to solubilize quickly in any liquid medium such as gastrointestinal fluids. It influence the release of the encased drug in the body. Pharmaceutical companies are providing their formulations with sugar coatings owing to its unique features. Hence, growing pharma industry, increasing number of pharmaceutical companies and raised demand for sugar coatings tablets for wide range of therapeutic areas are responsible for the market growth.

The market study is broken down by Type (Colored Sugar Coated Tablets and Colorless Sugar Coated Tablets), by Application (Cardiovascular Diseases, Gastrointestinal Disease, Neurological Diseases, Immune Disease, Gynaecological, Orthopaedic diseases and Others) and major geographies with country level break-up.

There are various companies are operating in the market to provides sugar coatings tablets. Pharmaceutical companies provides their medications which are coated with sugar. This coatings are easy to digest and it provides safe coverings to the API. Hence the demand for this tablets is continue to rise which gaining attention from the number of market players for their entry. The market leaders are investing on organic and non-organic strategic growth initiatives to become dominant in this industry.

Pfizer (United States), Novartis ( Switzerland), Bayer( Germany), Yangze River Pharmacelltcal (China), Harbin Pharmaceutical(China), Healthy Life Pharma Pvt. Ltd.(India), Gsk (United Kingdom) and Gebro (Austria) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Jining USP International Co., Ltd. (China) and Reyoung Pharmaceutical Co., Ltd. (China).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Sugar Coated Tablets market by Type, Application and Region.

On the basis of geography, the market of Sugar Coated Tablets has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Binders, the sub-segment i.e. Polyvinyl Acetate (PVA) will boost the Sugar Coated Tablets market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • The use of enteric sugar coatings for tablet coatings

Market Drivers
  • Rising number of pharmaceutical companies across the globe
  • Augmented demand for sugar coating tablet from wide range of therapeutic areas
  • Unique features like protecting the tablet content from acidic conditions of stomach, prevent damages to internal content and formulations impacting on the demand in positive manner

Opportunities
  • Unique features like affordable in terms of running costs, easily availability of raw material like sugar and water, low capital cost providing opportunity to the market for their growth
  • Ongoing research & development to make sugar-coated tablets functioning in more number of disease cases is projected to create opportunity for the market

Restraints
  • Time consuming production and expertise requirement for coating process may hamper inclination of coatings manufacturers which will eventually impact in negative manner on the market
  • Strengthen government norms for coating production

Challenges
  • It requires specialized and trained personnel hence, overcome the lack of trained personnel is key challenge to the market


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Pharmaceutical Companies, Sugar Coatings Tablet Manufacturers, Suppliers and Distributors, Government Regulatory, Research Organizations and chemical laboratories and End-Use Industries

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Colored Sugar Coated Tablets
  • Colorless Sugar Coated Tablets
By Application
  • Cardiovascular Diseases
  • Gastrointestinal Disease
  • Neurological Diseases
  • Immune Disease
  • Gynaecological
  • Orthopaedic diseases
  • Others
By Binders
  • Polyvinyl Acetate (PVA)
  • Polyvinyl Pyrrolidone (PVP)
  • Cellulose
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising number of pharmaceutical companies across the globe
      • 3.2.2. Augmented demand for sugar coating tablet from wide range of therapeutic areas
      • 3.2.3. Unique features like protecting the tablet content from acidic conditions of stomach, prevent damages to internal content and formulations impacting on the demand in positive manner
    • 3.3. Market Challenges
      • 3.3.1. It requires specialized and trained personnel hence, overcome the lack of trained personnel is key challenge to the market
    • 3.4. Market Trends
      • 3.4.1. The use of enteric sugar coatings for tablet coatings
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sugar Coated Tablets, by Type, Application, Binders and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Sugar Coated Tablets (Value)
      • 5.2.1. Global Sugar Coated Tablets by: Type (Value)
        • 5.2.1.1. Colored Sugar Coated Tablets
        • 5.2.1.2. Colorless Sugar Coated Tablets
      • 5.2.2. Global Sugar Coated Tablets by: Application (Value)
        • 5.2.2.1. Cardiovascular Diseases
        • 5.2.2.2. Gastrointestinal Disease
        • 5.2.2.3. Neurological Diseases
        • 5.2.2.4. Immune Disease
        • 5.2.2.5. Gynaecological
        • 5.2.2.6. Orthopaedic diseases
        • 5.2.2.7. Others
      • 5.2.3. Global Sugar Coated Tablets by: Binders (Value)
        • 5.2.3.1. Polyvinyl Acetate (PVA)
        • 5.2.3.2. Polyvinyl Pyrrolidone (PVP)
        • 5.2.3.3. Cellulose
        • 5.2.3.4. Others
      • 5.2.4. Global Sugar Coated Tablets Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Sugar Coated Tablets: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis ( Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer( Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Yangze River Pharmacelltcal (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Harbin Pharmaceutical(China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Healthy Life Pharma Pvt. Ltd.(India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Gsk (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Gebro (Austria)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Sugar Coated Tablets Sale, by Type, Application, Binders and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Sugar Coated Tablets (Value)
      • 7.2.1. Global Sugar Coated Tablets by: Type (Value)
        • 7.2.1.1. Colored Sugar Coated Tablets
        • 7.2.1.2. Colorless Sugar Coated Tablets
      • 7.2.2. Global Sugar Coated Tablets by: Application (Value)
        • 7.2.2.1. Cardiovascular Diseases
        • 7.2.2.2. Gastrointestinal Disease
        • 7.2.2.3. Neurological Diseases
        • 7.2.2.4. Immune Disease
        • 7.2.2.5. Gynaecological
        • 7.2.2.6. Orthopaedic diseases
        • 7.2.2.7. Others
      • 7.2.3. Global Sugar Coated Tablets by: Binders (Value)
        • 7.2.3.1. Polyvinyl Acetate (PVA)
        • 7.2.3.2. Polyvinyl Pyrrolidone (PVP)
        • 7.2.3.3. Cellulose
        • 7.2.3.4. Others
      • 7.2.4. Global Sugar Coated Tablets Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sugar Coated Tablets: by Type(USD Million)
  • Figure 4. Global Sugar Coated Tablets: by Type USD Million (2015-2020)
  • Table 2. Sugar Coated Tablets Colored Sugar Coated Tablets , by Region USD Million (2015-2020)
  • Table 3. Sugar Coated Tablets Colorless Sugar Coated Tablets , by Region USD Million (2015-2020)
  • Table 4. Sugar Coated Tablets: by Application(USD Million)
  • Figure 5. Global Sugar Coated Tablets: by Application USD Million (2015-2020)
  • Table 5. Sugar Coated Tablets Cardiovascular Diseases , by Region USD Million (2015-2020)
  • Table 6. Sugar Coated Tablets Gastrointestinal Disease , by Region USD Million (2015-2020)
  • Table 7. Sugar Coated Tablets Neurological Diseases , by Region USD Million (2015-2020)
  • Table 8. Sugar Coated Tablets Immune Disease , by Region USD Million (2015-2020)
  • Table 9. Sugar Coated Tablets Gynaecological , by Region USD Million (2015-2020)
  • Table 10. Sugar Coated Tablets Orthopaedic diseases , by Region USD Million (2015-2020)
  • Table 11. Sugar Coated Tablets Others , by Region USD Million (2015-2020)
  • Table 12. Sugar Coated Tablets: by Binders(USD Million)
  • Figure 6. Global Sugar Coated Tablets: by Binders USD Million (2015-2020)
  • Table 13. Sugar Coated Tablets Polyvinyl Acetate (PVA) , by Region USD Million (2015-2020)
  • Table 14. Sugar Coated Tablets Polyvinyl Pyrrolidone (PVP) , by Region USD Million (2015-2020)
  • Table 15. Sugar Coated Tablets Cellulose , by Region USD Million (2015-2020)
  • Table 16. Sugar Coated Tablets Others , by Region USD Million (2015-2020)
  • Table 17. South America Sugar Coated Tablets, by Country USD Million (2015-2020)
  • Figure 7. South America Sugar Coated Tablets Share (%), by Country
  • Table 18. South America Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 19. South America Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 20. South America Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 21. Brazil Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 22. Brazil Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 23. Brazil Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 24. Argentina Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 25. Argentina Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 26. Argentina Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 27. Rest of South America Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 30. Asia Pacific Sugar Coated Tablets, by Country USD Million (2015-2020)
  • Figure 8. Asia Pacific Sugar Coated Tablets Share (%), by Country
  • Table 31. Asia Pacific Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 32. Asia Pacific Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 33. Asia Pacific Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 34. China Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 35. China Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 36. China Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 37. Japan Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 38. Japan Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 39. Japan Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 40. India Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 41. India Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 42. India Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 43. South Korea Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 44. South Korea Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 45. South Korea Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 46. Taiwan Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 47. Taiwan Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 48. Taiwan Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 49. Australia Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 50. Australia Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 51. Australia Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 55. Europe Sugar Coated Tablets, by Country USD Million (2015-2020)
  • Figure 9. Europe Sugar Coated Tablets Share (%), by Country
  • Table 56. Europe Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 57. Europe Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 58. Europe Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 59. Germany Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 60. Germany Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 61. Germany Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 62. France Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 63. France Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 64. France Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 65. Italy Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 66. Italy Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 67. Italy Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 68. United Kingdom Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 69. United Kingdom Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 70. United Kingdom Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 71. Netherlands Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 72. Netherlands Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 73. Netherlands Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 74. Rest of Europe Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 75. Rest of Europe Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 76. Rest of Europe Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 77. MEA Sugar Coated Tablets, by Country USD Million (2015-2020)
  • Figure 10. MEA Sugar Coated Tablets Share (%), by Country
  • Table 78. MEA Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 79. MEA Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 80. MEA Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 81. Middle East Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 82. Middle East Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 83. Middle East Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 84. Africa Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 85. Africa Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 86. Africa Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 87. North America Sugar Coated Tablets, by Country USD Million (2015-2020)
  • Figure 11. North America Sugar Coated Tablets Share (%), by Country
  • Table 88. North America Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 89. North America Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 90. North America Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 91. United States Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 92. United States Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 93. United States Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 94. Canada Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 95. Canada Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 96. Canada Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Table 97. Mexico Sugar Coated Tablets, by Type USD Million (2015-2020)
  • Table 98. Mexico Sugar Coated Tablets, by Application USD Million (2015-2020)
  • Table 99. Mexico Sugar Coated Tablets, by Binders USD Million (2015-2020)
  • Figure 12. Global Sugar Coated Tablets share by Players 2020 (%)
  • Figure 13. Global Sugar Coated Tablets share by Players (Top 3) 2020(%)
  • Figure 14. Global Sugar Coated Tablets share by Players (Top 5) 2020(%)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Sugar Coated Tablets: by Type(USD Million)
  • Figure 32. Global Sugar Coated Tablets: by Type USD Million (2020-2025)
  • Table 109. Sugar Coated Tablets Colored Sugar Coated Tablets , by Region USD Million (2020-2025)
  • Table 110. Sugar Coated Tablets Colorless Sugar Coated Tablets , by Region USD Million (2020-2025)
  • Table 111. Sugar Coated Tablets: by Application(USD Million)
  • Figure 33. Global Sugar Coated Tablets: by Application USD Million (2020-2025)
  • Table 112. Sugar Coated Tablets Cardiovascular Diseases , by Region USD Million (2020-2025)
  • Table 113. Sugar Coated Tablets Gastrointestinal Disease , by Region USD Million (2020-2025)
  • Table 114. Sugar Coated Tablets Neurological Diseases , by Region USD Million (2020-2025)
  • Table 115. Sugar Coated Tablets Immune Disease , by Region USD Million (2020-2025)
  • Table 116. Sugar Coated Tablets Gynaecological , by Region USD Million (2020-2025)
  • Table 117. Sugar Coated Tablets Orthopaedic diseases , by Region USD Million (2020-2025)
  • Table 118. Sugar Coated Tablets Others , by Region USD Million (2020-2025)
  • Table 119. Sugar Coated Tablets: by Binders(USD Million)
  • Figure 34. Global Sugar Coated Tablets: by Binders USD Million (2020-2025)
  • Table 120. Sugar Coated Tablets Polyvinyl Acetate (PVA) , by Region USD Million (2020-2025)
  • Table 121. Sugar Coated Tablets Polyvinyl Pyrrolidone (PVP) , by Region USD Million (2020-2025)
  • Table 122. Sugar Coated Tablets Cellulose , by Region USD Million (2020-2025)
  • Table 123. Sugar Coated Tablets Others , by Region USD Million (2020-2025)
  • Table 124. South America Sugar Coated Tablets, by Country USD Million (2020-2025)
  • Figure 35. South America Sugar Coated Tablets Share (%), by Country
  • Table 125. South America Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 126. South America Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 127. South America Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 128. Brazil Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 129. Brazil Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 130. Brazil Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 131. Argentina Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 132. Argentina Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 133. Argentina Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 134. Rest of South America Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 135. Rest of South America Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 136. Rest of South America Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 137. Asia Pacific Sugar Coated Tablets, by Country USD Million (2020-2025)
  • Figure 36. Asia Pacific Sugar Coated Tablets Share (%), by Country
  • Table 138. Asia Pacific Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 139. Asia Pacific Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 140. Asia Pacific Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 141. China Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 142. China Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 143. China Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 144. Japan Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 145. Japan Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 146. Japan Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 147. India Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 148. India Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 149. India Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 150. South Korea Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 151. South Korea Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 152. South Korea Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 153. Taiwan Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 154. Taiwan Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 155. Taiwan Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 156. Australia Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 157. Australia Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 158. Australia Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 159. Rest of Asia-Pacific Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 160. Rest of Asia-Pacific Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 161. Rest of Asia-Pacific Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 162. Europe Sugar Coated Tablets, by Country USD Million (2020-2025)
  • Figure 37. Europe Sugar Coated Tablets Share (%), by Country
  • Table 163. Europe Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 164. Europe Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 165. Europe Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 166. Germany Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 167. Germany Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 168. Germany Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 169. France Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 170. France Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 171. France Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 172. Italy Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 173. Italy Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 174. Italy Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 175. United Kingdom Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 176. United Kingdom Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 177. United Kingdom Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 178. Netherlands Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 179. Netherlands Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 180. Netherlands Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 181. Rest of Europe Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 182. Rest of Europe Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 183. Rest of Europe Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 184. MEA Sugar Coated Tablets, by Country USD Million (2020-2025)
  • Figure 38. MEA Sugar Coated Tablets Share (%), by Country
  • Table 185. MEA Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 186. MEA Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 187. MEA Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 188. Middle East Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 189. Middle East Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 190. Middle East Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 191. Africa Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 192. Africa Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 193. Africa Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 194. North America Sugar Coated Tablets, by Country USD Million (2020-2025)
  • Figure 39. North America Sugar Coated Tablets Share (%), by Country
  • Table 195. North America Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 196. North America Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 197. North America Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 198. United States Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 199. United States Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 200. United States Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 201. Canada Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 202. Canada Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 203. Canada Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 204. Mexico Sugar Coated Tablets, by Type USD Million (2020-2025)
  • Table 205. Mexico Sugar Coated Tablets, by Application USD Million (2020-2025)
  • Table 206. Mexico Sugar Coated Tablets, by Binders USD Million (2020-2025)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 17. Pfizer (United States) Revenue: by Geography 2020
  • Figure 18. Novartis ( Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. Novartis ( Switzerland) Revenue: by Geography 2020
  • Figure 20. Bayer( Germany) Revenue, Net Income and Gross profit
  • Figure 21. Bayer( Germany) Revenue: by Geography 2020
  • Figure 22. Yangze River Pharmacelltcal (China) Revenue, Net Income and Gross profit
  • Figure 23. Yangze River Pharmacelltcal (China) Revenue: by Geography 2020
  • Figure 24. Harbin Pharmaceutical(China) Revenue, Net Income and Gross profit
  • Figure 25. Harbin Pharmaceutical(China) Revenue: by Geography 2020
  • Figure 26. Healthy Life Pharma Pvt. Ltd.(India) Revenue, Net Income and Gross profit
  • Figure 27. Healthy Life Pharma Pvt. Ltd.(India) Revenue: by Geography 2020
  • Figure 28. Gsk (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Gsk (United Kingdom) Revenue: by Geography 2020
  • Figure 30. Gebro (Austria) Revenue, Net Income and Gross profit
  • Figure 31. Gebro (Austria) Revenue: by Geography 2020
Some of the key companies/manufacturers profiled in the report
  • Pfizer (United States)
  • Novartis ( Switzerland)
  • Bayer( Germany)
  • Yangze River Pharmacelltcal (China)
  • Harbin Pharmaceutical(China)
  • Healthy Life Pharma Pvt. Ltd.(India)
  • Gsk (United Kingdom)
  • Gebro (Austria)
Additional players considered in the study are as follows:
Jining USP International Co., Ltd. (China) , Reyoung Pharmaceutical Co., Ltd. (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation